Registry of Lobbyists
Total Number of Communication Reports: 0
Monthly communication reports in the last 6 months: 0
Version 1 of 12 (2005-04-26 to 2005-10-06) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Consultant lobbyist name: | CARL BALTARE Lobbyist business address |
| Consulting firm: |
GLOBAL PUBLIC AFFAIRS
WORLD EXCHANGE PLAZA OTTAWA, ON K1P 1A4 Canada |
| Position: | CONSULTANT |
| Telephone number: | 613-782-2336 |
| Fax number: | 613-782-2428 |
| Former public office holder: | Yes |
| Payment is contingent on the success of the undertaking: | No |
| Client: |
NOVARTIS
385 BOUCHARD BLVD DORVAL, QC H9S 1A9 Canada |
| Telephone number: | 514-633-7852 |
| Fax number: | 514-631-4856 |
| Client Representative: |
PIER GIORGIO
FONTANA
|
| Parent: | The client is not a subsidiary of any other parent companies. |
| Coalition: | The client is not a coalition. |
| Subsidiary: | The client does not have any subsidiaries that could be affected by the outcome of the undertaking. |
| Individual, organization or corporation: | The client's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
| Was the client funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Industry Canada, Patented Medicine Prices Review Board (PMPRB) | ||||||
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format | ||||||
| Subject Matter: Areas of Concern: | Consumer Issues, Health, Industry, Intellectual Property, Science and Technology | ||||||
Details Regarding the Identified Subject Matter
|
|||||||